top of page


Overview of My Research

Dr. J. James Frost received his M.D. and Ph.D. degrees from Washington University; his Ph.D. degree is in nuclear and radiochemistry. He also obtained an M.B.A. degree from John Hopkins University.  Currently, Dr. Frost is President of BioMolecular Imaging and Retired Professor at The Johns Hopkins University School of Medicine, Department of Radiology.

  • Cancer investigator

  • Molecular imaging Specialist

  • Clinical trials reader

  • Clinical radiology and nuclear medicine

  • Consulting for pharma, CROs, diagnostics, and biotech

Home: Welcome
Home: Blog Feed


Dr. J. James Frost's focus in chemistry was nuclear and radiochemistry, which involved instruction in nuclear structure, quantum mechanics, and higher mathematics. Dr. J. James Frost's areas of focus involve fundamental symmetries and broken symmetries that are the basis of many scientific theories and which pervade the natural world.

"This early exposure and training became reanimated when I conceived and wrote a scientific paper in 2018 on symmetry and symmetry-breaking in cancer " ...a belated demonstration of foundational qualities of chemistry.

Then in Jim founded BioMolecular Imaging Consultants where he provides expert advice on anatomic & molecular imaging from entire organ systems to small molecules, peptides & antibodies for use in early clinical and clinical settings, trial design, data analysis, image reading as well as with all FDA liaisons, CROs and academic imaging sites.

Home: About Me



Served as the internal clinical imaging expert for a large public biotech company in a FIH clinical trial for a novel cancer imaging radiolabeled peptide


Chaired an advisory board meeting for a large US corporation for post approval rollout and a new CNS probe-specific imaging workstation.


Evaluated U.S. imaging CRO’s for a large international CRO during a multi-month project to select an imaging CRO partner


Developed an imaging strategy, created imaging protocols, and identified preclinical/clinical imaging sites for an antibody cancer therapeutic program of a public biotech corporation


Developed and evaluated post approval strategies and phase IV imaging opportunities for a large pharma CNS diagnostic imaging agent


Provided due diligence guidance to a venture capital company in consideration of funding a preclinical CRO start-up. Identified and interfaced with additional VC’s for syndication funding


Advised a large pharma company in the development of an imaging strategy and protocol to examine CNS side effects of a new drug candidate


Developed a business plan and scientific strategy for a diagnostic cancer imaging start-up company


Developed an imaging strategy and experimental design for a novel organ imaging need of a small cap pharmaceutical company

Home: Research
Home: Video
The Johns Hopkins University School of Medicine 2023 Cancer TIME Student Tutorial
Dr. J. James Frost

The Johns Hopkins University School of Medicine 2023 Cancer TIME Student Tutorial

The Johns Hopkins University School of Medicine offers a series of Topics in Interdisciplinary Medicine (TIME) courses as part of its Genes to Society medical student curriculum. As part of this year’s Cancer TIME program I taught the Frontiers in Cancer Therapy track with Dr. Shawn Lupold from the Department of Urology. This year was the 7th that Dr. Lupold and I taught. We had a record-breaking 11 students sign up for our section. Several of the students who selected this track planned to pursue post-graduate residency training in diverse specialties that include cancer care and others stated that they just wanted to improve their knowledge of cutting-edge cancer treatments. On the first day, Dr. Lupold and I presented a cancer overview lecture on new approaches to cancer therapy. Dr. Lupold presented on new molecular cancer treatments based off the Hallmarks of Cancer. I presented an overview of game theory and adaptive paradigms for cancer treatment. Each year brings many new molecular treatments and adaptive dosing approaches for optimal outcomes. On days 2 and 3, the students presented a recent article they chose from a list of over 40 new curated articles Dr. Lupold and I created. The topic categories included; - Prevention - Microenvironment mechanisms - Targeted therapies - Combination therapies - Immunotherapy - Gene therapy - Biomarker targeted therapy - Therapeutic dosing and tumor response; and - Cancer physics, computation and information - A new category this year was “drugging the undruggable targets”. “This is an exceedingly rewarding experience each year I teach the course. I learn a lot from the high level discussions by these outstanding Johns Hopkins medical students.”- Dr. J. James Frost, of BioMolecular Imaging. The publications presented by the students spanned a wide array of topics. There were 5 articles that dealt with cancer prevention. There were 3 on clinical trials that focused on the polio virus, IDH mutants, and high folate alpha expression. A cancer screening article examined the role of MRI in prostate biopsy for prostate cancer. A game theory article dealt with optimization of treatment for prostate and other cancers. Finally, a truly novel approach examined the scientific feasibility of silencing mutant KRAS by inducing its misfolding and aggregation, much like amyloid aggregation in the brain. To see the compete list of 2023 Cancer TIME Student Tutorial Articles please visit the blog post here Direct Contact E-mail: DRJJAMESFROST@GMAIL.COM Website: Twitter: Facebook: LinkedIn: SoundCloud: ORCHID ID:
Dr. J. James Frost | Cancer's Computation & Communication
Dr. J. James Frost

Dr. J. James Frost | Cancer's Computation & Communication

The trade-offs between communication and computation in cancer wasn't something I was thinking about when I wrote Cancer’s Intelligence. I purely considered the computational and decision engine aspects of cancer as an intelligent biologic entity. However, a recent publication entitled Communication consumes 35 times more energy than computation in the human cortex, but both costs are needed to predict synapse number by WB Levy and VG Calvert sharply points out to me that I had omitted an important counterpart of computation: communication. I thought to myself, "Communication or information transfer is essential to transmit the results of an intelligent decision engine of any system to the active components of that system." Since energy is always limited, the optimal balance between computation and communication is a requirement for cancer's efficient survival as a system of genotypically and phenotypically diverse cells, from the primary tumor to the tumor microenvironment to metastases and the metastatic niche. As Levy and Calvert carefully examine the energetic costs for computation and communication in the brain, so must we accomplish the same for cancer, including bits per joule, channel capacity, and maximal entropy constraints on efficiency. In contrast to the human brain, for cancer the goal is to understand computation and communication in order to radically disrupt them and destroy the cancer. Cancer is currently attacked by disrupting communication at the level of cellular receptors and other signaling proteins, but there is no well understood underlying theory to guide treatment from the communication or computation standpoints. In Cancer’s Intelligence I outlined several approaches to the cancer computation problem and in Symmetry and symmetry breaking in cancer: a foundational approach to the cancer problem I outlined some approaches to blocking communication, e.g., attacking cancer network nodes of greatest broken symmetry where network vulnerability is highest. Future cancer investigations will benefit by taking note of the Levy and Calvert work and creating similar theoretical underpinnings for cancer. References: William B Levy Victoria G. Calvert Keywords: computation and communication modeling models, physical computing, system functions, scientific study, Trade-offs and Sensor Selection energy For more information on cancer, intelligence, computation, game theory, Boolean network, please view the FULL TEXT HERE CONTACT: E-mail: DRJJAMESFROST@GMAIL.COM Website: Twitter: Facebook: LinkedIn: SoundCloud: ORCHID ID:


Thanks for submitting!

Home: Contact
bottom of page